LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-98 Cr | ₹-79 Cr | ₹-57 Cr | ₹-37 Cr | ₹-78 Cr |
What is the latest Cash Flow from Investing Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-98 Cr |
| Mar2025 | ₹-79 Cr |
| Mar2024 | ₹-57 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-78 Cr |
How is Cash Flow from Investing Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-98 Cr | Negative | |
| Mar2025 | ₹-79 Cr | Negative | |
| Mar2024 | ₹-57 Cr | Negative | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-78 Cr | - | |
Compare Cash Flow from Investing Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,065.6 Cr | -3.2% | -11.4% | 4.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -3.2% |
-11.4% |
4.1% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses